Skip to main content

Enveric Biosciences, Inc.

corporate_fare Company Profile

Enveric Biosciences, Inc.

ENVB·NASDAQ·Life Sciences·CIK 0000890821

Enveric Biosciences, Inc. was incorporated in Delaware in February 1994. The company's business history includes a reverse merger on May 26, 2015, with Ameri and Partners Inc., at which point the company changed its name to AMERI Holdings, Inc. The Ameri business was spun off on December 30, 2020. On the same date, the company completed a tender offer to acquire all outstanding common shares of Jay Pharma Inc., a Canada corporation, and subsequently changed its name to "Enveric Biosciences, Inc." On September 16, 2021, the company completed an amalgamation under the British Columbia Business Corporations Act, indirectly acquiring all outstanding securities of MagicMed Industries Inc., a corporation existing under the laws of the Province of British Columbia. Following this, the amalgamated corporation became an indirect wholly-owned subsidiary of Enveric Biosciences, Inc. The company's principal corporate office is located at 245 First Street, Riverview II, 18th Floor, Cambridge, MA 02142.

Enveric Biosciences, Inc. (NASDAQ:ENVB) is a publicly traded company in the Life Sciences sector. Wiseek monitors ENVB SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Enveric Biosciences Expands Highly Dilutive ATM Offering by $2.4M Amidst Going Concern Warning
  • Enveric Biosciences Unveils Q2 2026 Investor Presentation Highlighting Neuroplastogen Pipeline & EB-003 Progress
  • Enveric Biosciences' Lead Drug EB-003 Begins IND-Enabling Genotoxicity Studies
  • Shareholders Reject Massive Stock Increase, Approve Reverse Split Option for Distressed Enveric Biosciences
  • Lead Neuroplastogen Candidate EB-003 Shows Positive Preclinical Safety, No Photoreactive Potential

Financial Snapshot

Fiscal year ended December 31, 2025
Net Income
-$8.77M
Diluted EPS
-$36.24
Op. Cash Flow
-$8.14M
Operating Income
-$8.77M
Cash & Equivalents
$4.68M
Debt / Equity
0.00×
Shares Outstanding
1.06M sh
Source: 10-K · filed 2026-03-27 · accession 0001493152-26-013294
Browse all tickers starting with E →
$1.52 -0.01% today
52-week range · as of 2026-06-09 $1.6 – $17.64
Market cap
$5.63M
Volume
1.8M (5.8× avg)
3-mo avg 305.9K
Live data · 2026-06-12 23:08 UTC · After hours

show_chartPrice Chart

Loading chart...

feed ENVB - Latest Insights

ENVB
Jun 09, 2026, 5:15 PM EDT
Filing Type: 424B5
Importance Score:
9
Price at Filing: $1.63
Real-time Price: $1.52 info
Change: -$0.110 (-7%) info
Market Cap: $5.633M info
ENVB
Jun 08, 2026, 5:53 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.71
Real-time Price: $1.52 info
Change: -$0.190 (-11%) info
Market Cap: $5.633M info
ENVB
Jun 02, 2026, 8:04 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $2.20
Real-time Price: $1.52 info
Change: -$0.680 (-31%) info
Market Cap: $5.633M info
ENVB
May 29, 2026, 4:13 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $2.30
Real-time Price: $1.52 info
Change: -$0.780 (-34%) info
Market Cap: $5.633M info
ENVB
May 19, 2026, 8:41 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $2.00
Real-time Price: $1.52 info
Change: -$0.480 (-24%) info
Market Cap: $5.633M info
ENVB
May 15, 2026, 8:05 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $2.26
Real-time Price: $1.52 info
Change: -$0.740 (-33%) info
Market Cap: $5.633M info
ENVB
May 15, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $2.26
Real-time Price: $1.52 info
Change: -$0.7439 (-33%) info
Market Cap: $5.633M info
ENVB
May 15, 2026, 8:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $2.26
Real-time Price: $1.52 info
Change: -$0.7439 (-33%) info
Market Cap: $5.633M info
ENVB
May 05, 2026, 8:13 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $3.48
Real-time Price: $1.52 info
Change: -$1.96 (-56%) info
Market Cap: $5.633M info
ENVB
Apr 30, 2026, 4:03 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $3.82
Real-time Price: $1.52 info
Change: -$2.30 (-60%) info
Market Cap: $5.633M info
ENVB
Apr 30, 2026, 4:02 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.82
Real-time Price: $1.52 info
Change: -$2.30 (-60%) info
Market Cap: $5.633M info
ENVB
Apr 29, 2026, 5:27 PM EDT
Filing Type: 424B3
Importance Score:
9
Price at Filing: $5.19
Real-time Price: $1.52 info
Change: -$3.67 (-71%) info
Market Cap: $5.633M info
ENVB
Apr 23, 2026, 4:30 PM EDT
Filing Type: S-3
Importance Score:
9
Price at Filing: $3.92
Real-time Price: $1.52 info
Change: -$2.40 (-61%) info
Market Cap: $5.633M info
ENVB
Apr 17, 2026, 6:42 PM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $1.83
Real-time Price: $1.52 info
Change: -$0.310 (-17%) info
Market Cap: $5.633M info
ENVB
Apr 03, 2026, 5:05 PM EDT
Filing Type: PRE 14A
Importance Score:
9
Price at Filing: $2.00
Real-time Price: $1.52 info
Change: -$0.480 (-24%) info
Market Cap: $5.633M info
ENVB
Mar 27, 2026, 5:35 PM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $1.85
Real-time Price: $1.52 info
Change: -$0.330 (-18%) info
Market Cap: $5.633M info
ENVB
Mar 27, 2026, 5:27 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $1.88
Real-time Price: $1.52 info
Change: -$0.360 (-19%) info
Market Cap: $5.633M info
ENVB
Mar 27, 2026, 5:25 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.88
Real-time Price: $1.52 info
Change: -$0.360 (-19%) info
Market Cap: $5.633M info
ENVB
Feb 09, 2026, 9:28 PM EST
Filing Type: S-1
Importance Score:
9
Price at Filing: $2.12
Real-time Price: $1.52 info
Change: -$0.6025 (-28%) info
Market Cap: $5.633M info
ENVB
Feb 06, 2026, 4:30 PM EST
Filing Type: 424B5
Importance Score:
9
Price at Filing: $2.37
Real-time Price: $1.52 info
Change: -$0.850 (-36%) info
Market Cap: $5.633M info